Related Experiment Videos
A carbamazepine trial in chronic, treatment-refractory schizophrenia
1Clinical Research Unit, Metropolitan State Hospital, Norwalk, CA 90650.
The American Journal of Psychiatry
|June 1, 1988
Abstract:
Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks. No overall change was found, but four patients significantly improved while eight worsened. Given the paucity of successful treatments for refractory schizophrenia, further study of carbamazepine appears warranted.